Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 245 results.
User Information
Export Records
  1. 1.   Virologic effects of broadly neutralizing antibodies VRC01LS and VRC07-523LS on chronic HIV-1 infection
  2. Happe, Myra; Lynch, Rebecca M; Fichtenbaum, Carl J; Heath, Sonya L; Koletar, Susan L; Landovitz, Raphael J; Presti, Rachel M; Santana-Bagur, Jorge L; Tressler, Randall L; Holman, LaSonji A; Novik, Laura; Roa, Jhoanna C; Rothwell, Ro Shauna; Strom, Larisa; Wang,Jing; Hu, Zonghui; Conan-Cibotti, Michelle; Bhatnagar, Anjali M; Dwyer, Bridget; Ko, Sung Hee; Belinky, Frida; Namboodiri, Aryan M; Pandey, Janardan P; Carroll, Robin; Basappa, Manjula; Serebryannyy, Leonid; Narpala, Sandeep R; Lin, Bob C; McDermott, Adrian B; Boritz, Eli A; Capparelli, Edmund V; Coates, Emily E; Koup, Richard A; Ledgerwood, Julie E; Mascola, John R; Chen, Grace L; Tebas, Pablo
  3. JCI Insight. 2025, Feb 24; 10(4):
  1. 2.   Examining the bias-efficiency tradeoff from incorporation of nonconcurrent controls in platform trials: A simulation study example from the adaptive COVID-19 treatment trial
  2. Bonnett,Tyler; Potter, Gail E; Dodd, Lori E
  3. Clinical Trials (London, England). 2025, Feb 08; 17407745251313928.
  1. 3.   TRa1 mutant suppresses KLF9 to cause endometrial metaplasia with ectopic IL-33 expression leading to uterine fibrosis and infertility
  2. Edmondson,Elijah; Kimura, Takahito; Hwang, Eunmi; Kim, Minjun; Warner,Andrew; Zhu, Yuelin; Zhao, Li; Yu, Yanlin; Zhu, Xuguang; Hernandez, Maria; Kedei, Noemi; Cheng, Sheue-Yann
  3. Scientific Reports. 2025, Jan 31; 15(1): 3892.
  1. 4.   A Mixed Methods Study of Medication Adherence in Adults with Neurofibromatosis Type 1 (NF1) on a Clinical Trial of Selumetinib
  2. Curlee, Millicent S; Toledo-Tamula, Mary Anne; Baker, Melissa; Wikstrom, Daniel; Harrison, Cynthia; Rhodes, Amanda; Fagan, Margaret; Tibery,Cecilia; Wolters, Pamela L; Widemann, Brigitte C; Gross, Andrea M; Martin, Staci
  3. Cancers. 2025, Jan 17; 17(2):
  1. 5.   Associations Between Mosaic Loss of Sex Chromosomes and Incident Hospitalization for Atrial Fibrillation in the United Kingdom
  2. Lim, Jungeun; Hubbard, Aubrey K; Blechter, Batel; Shi, Jianxin; Zhou,Weiyin; Loftfield, Erikka; Machiela, Mitchell J; Wong, Jason Y Y
  3. Journal of the American Heart Association. 2024, Nov 19; 13(22): e036984.
  1. 6.   Gene Co-Expression Network Analysis Associated with Endometrial Cancer Tumorigenesis and Survival Outcomes
  2. Clark, Alexis J; Singh, Rajesh; Leonis, Regina L; Stahlberg, Eric A; Clark, Zachary S; Lillard, James W
  3. International Journal of Molecular Sciences. 2024, Nov 18; 25(22):
  1. 7.   Practical application of good participatory practices for trials of emerging pathogens: Developing materials for use in ACTIV-3, -3b, and ACTIV-associated COVID-19 trials
  2. Guerra-de-Blas, Paola Del Carmen; Marines-Price, Rubria; Milman, Olga; Deal,Danae; Marchand,Jon; Linton,Jessica; Meger, Sue; Rule, John; Holland, Thomas L; Kitonsa, Jonathan; Delph, Yvette
  3. Journal of Clinical and Translational Science. 2024, Oct 15; 8(1): e157.
  1. 8.   SARS-CoV-2 RNA and nucleocapsid antigen are blood biomarkers associated with severe disease outcomes that improve in response to remdesivir
  2. Singh, Kanal; Rubenstein,Kevin; Callier,Viviane; Shaw-Saliba, Katy; Rupert,Adam; Dewar,Robin; Laverdure,Sylvain; Highbarger,Helene; Lallemand,Perrine; Huang, Meei-Li; Jerome, Keith R; Sampoleo, Reigran; Mills, Margaret G; Greninger, Alexander L; Juneja, Kavita; Porter, Danielle; Benson, Constance A; Dempsey, Walla; El Sahly, Hana M; Focht, Chris; Jilg, Nikolaus; Paules, Catharine I; Rapaka, Rekha R; Uyeki, Timothy M; Lane, H Clifford; Beigel, John; Dodd, Lori E
  3. The Journal of Infectious Diseases. 2024, Sep 23; 230(3): 624-634.
  1. 9.   Focusing HIV-1 Gag T-cell Responses to Highly Conserved Regions by DNA Vaccination in HVTN 119
  2. Kalams, Spyros A; Felber,Barbara; Mullins, James I; Scott, Hyman M; Allen, Mary A; De Rosa, Stephen C; Heptinstall, Jack; Tomaras, Georgia D; Hu, Jiani; deCamp, Allan C; Rosati,Margherita; Bear,Jenifer; Pensiero, Michael N; Eldridge, John; Egan, Michael A; Hannaman, Drew; McElrath, M Juliana; Pavlakis,George
  3. JCI Insight. 2024, Aug 01;
  1. 10.   Recommendations for assessing appearance concerns related to plexiform and cutaneous neurofibromas in neurofibromatosis 1 clinical trials
  2. Merker, Vanessa L; Thompson, Heather L; Wolters, Pamela L; Buono, Frank D; Hingtgen, Cynthia M; Rosser, Tena; Barton, Belinda; Barnett, Carolina; Smith, Taylor; Haberkamp, Diana; McManus, Miranda L; Baldwin,Andrea; Moss, Irene P; Röhl, Claas; Martin, Staci
  3. Clinical Trials (London, England). 2023, Dec 23; 17407745231205577.
  1. 11.   Can incorporating genotyping data into efficacy estimators improve efficiency of early phase malaria vaccine trials?
  2. Potter, Gail E; Callier,Viviane; Shrestha, Biraj; Joshi, Sudhaunshu; Dwivedi, Ankit; Silva, Joana C; Laurens, Matthew B; Follmann, Dean A; Deye, Gregory A
  3. Malaria Journal. 2023, Dec 19; 22(1): 383.
  1. 12.   Pharmacodynamic effects of the PARP inhibitor talazoparib (MDV3800, BMN 673) in patients with BRCA-mutated advanced solid tumors
  2. Mittra, Arjun; Coyne, Geraldine H O' Sullivan; Zlott, Jennifer; Kummar, Shivaani; Meehan, Robert; Rubinstein, Lawrence; Juwara,Lamin; Wilsker,Deborah; Ji,Jay; Miller,Brandon; Navas, Tony; Ferry-Galow,Katherine; Voth,Andrea; Chang,Ting-Chia; Jiwani,Shahanawaz; Parchment,Ralph; Doroshow, James H; Chen, Alice P
  3. Cancer Chemotherapy and Pharmacology. 2023, Nov 27;
  1. 13.   Perspectives of adults with neurofibromatosis regarding the design of psychosocial trials: Results from an anonymous online survey
  2. Wolters, Pamela L; Al Ghriwati,Nour; Baker, Melissa; Martin, Staci; Berg, Dale; Erickson, Gregg; Franklin, Barbara; Merker, Vanessa L; Oberlander, Beverly; Reeve, Stephanie; Rohl, Claas; Rosser, Tena; Vranceanu, Ana-Maria
  3. Clinical Trials (London, England). 2023, Nov 14;
  1. 14.   Interim Analysis: Open-Label Extension Study of Leniolisib for Patients with APDS
  2. Rao, V Koneti; Kulm,Elaine; Šedivá, Anna; Plebani, Alessandro; Schuetz, Catharina; Shcherbina, Anna; Dalm, Virgil A; Trizzino, Antonino; Zharankova, Yulia; Webster, Sharon; Orpia, Alanvin; Körholz, Julia; Lougaris, Vassilios; Rodina, Yulia; Radford, Kath; Bradt, Jason; Relan, Anurag; Holland, Steven M; Lenardo, Michael J; Uzel, Gulbu
  3. The Journal of Allergy and clinical immunology.. 2023, Oct 03;
  1. 15.   A phase III randomized crossover trial of plerixafor versus G-CSF for treatment of WHIM syndrome
  2. McDermott, David H; Velez, Daniel; Cho, Elena; Cowen, Edward W; DiGiovanna, John J; Pastrana, Diana V; Buck, Christopher B; Calvo, Katherine R; Gardner, Pamela J; Rosenzweig, Sergio D; Stratton, Pamela; Merideth, Melissa A; Kim, H Jeffrey; Brewer, Carmen; Katz, James D; Kuhns,Doug; Malech, Harry L; Follmann, Dean; Fay, Michael P; Murphy, Philip M
  3. The Journal of Clinical Investigation. 2023, Oct 2; 133(19): e164918.
  1. 16.   Proteogenomic insights suggest druggable pathways in endometrial carcinoma
  2. Dou, Yongchao; Katsnelson, Lizabeth; Gritsenko, Marina A; Hu, Yingwei; Reva, Boris; Hong, Runyu; Wang, Yi-Ting; Kolodziejczak, Iga; Lu, Rita Jui-Hsien; Tsai, Chia-Feng; Bu, Wen; Liu, Wenke; Guo, Xiaofang; An, Eunkyung; Arend, Rebecca C; Bavarva, Jasmin; Chen, Lijun; Chu, Rosalie K; Czekanski, Andrzej; Davoli, Teresa; Demicco, Elizabeth G; DeLair, Deborah; Devereaux, Kelly; Dhanasekaran, Saravana M; Dottino, Peter; Dover, Bailee; Fillmore, Thomas L; Foxall, McKenzie; Hermann, Catherine E; Hiltke, Tara; Hostetter, Galen; Jedryka, Marcin; Jewell, Scott D; Johnson, Isabelle; Kahn, Andrea G; Ku, Amy T; Kumar-Sinha, Chandan; Kurzawa, Pawel; Lazar, Alexander J; Lazcano, Rossana; Lei, Jonathan T; Li, Yi; Liao, Yuxing; Lih, Tung-Shing M; Lin, Tai-Tu; Martignetti, John A; Masand, Ramya P; Matkowski, Rafal; McKerrow, Wilson; Mesri, Mehdi; Monroe, Matthew E; Moon, Jamie; Moore, Ronald J; Nestor, Michael D; Newton, Chelsea; Omelchenko, Tatiana; Omenn, Gilbert S; Payne, Samuel H; Petyuk, Vladislav A; Robles, Ana I; Rodriguez, Henry; Ruggles, Kelly V; Rykunov, Dmitry; Savage, Sara R; Schepmoes, Athena A; Shi, Tujin; Shi, Zhiao; Tan, Jimin; Taylor, Mason; Thiagarajan,Mathangi; Wang, Joshua M; Weitz, Karl K; Wen, Bo; Williams, C M; Wu, Yige; Wyczalkowski, Matthew A; Yi, Xinpei; Zhang, Xu; Zhao, Rui; Mutch, David; Chinnaiyan, Arul M; Smith, Richard D; Nesvizhskii, Alexey I; Wang, Pei; Wiznerowicz, Maciej; Ding, Li; Mani, D R; Zhang, Hui; Anderson, Matthew L; Rodland, Karin D; Zhang, Bing; Liu, Tao; Fenyö, David
  3. Cancer Cell. 2023, Sep 11; 41(9): 1586-1605.e15.
  1. 17.   Perspectives on Advancing Countermeasures for Filovirus Disease: Report from a Multi-Sector Meeting
  2. Sprecher, Armand; Cross, Robert; Marzi, Andrea; Martins, Karen A; Wolfe, Daniel; Montgomery, Joel M; Spiropoulou, Christina F; Cihlar, Tomas; Ahuka-Mundeke, Steve; Nyhuis, Tara; Teicher, Carrie; Crozier,Ian; Strong, Jim; Kobinger, Gary; Woolsey, Courtney; Geisbert, Thomas W; Feldmann, Heinz; Muyembe, Jean-Jacques
  3. The Journal of Infectious Diseases. 2023, Aug 19;
  1. 18.   A Single-Arm, Open-Label Phase II Study of ONC201 in Recurrent/Refractory Metastatic Breast Cancer and Advanced Endometrial Carcinoma
  2. Atkins, Sarah L P; Greer, Yoshimi Endo; Jenkins, Sarah; Gatti-Mays, Margaret E; Houston, Nicole; Lee, Sunmin; Lee, Min-Jung; Rastogi, Shraddha; Sato, Nahoko; Burks,Christina; Annunziata, Christina M; Lee, Jung-Min; Nagashima, Kunio; Trepel, Jane B; Lipkowitz, Stanley; Zimmer, Alexandra S
  3. The Oncologist. 2023, Jun 05;
  1. 19.   Evaluating Demographic Representation in Clinical Trials: Use of the Adaptive Coronavirus Disease 2019 Treatment Trial (ACTT) as a Test Case
  2. Ortega-Villa, Ana M; Hynes, Noreen A; Levine, Corri B; Yang, Katherine; Wiley, Zanthia; Jilg, Nikolaus; Wang,Jing; Whitaker, Jennifer A; Colombo, Christopher J; Nayak, Seema U; Kim, Hannah Jang; Iovine, Nicole M; Ince, Dilek; Cohen, Stuart H; Langer, Adam J; Wortham, Jonathan M; Atmar, Robert L; El Sahly, Hana M; Jain, Mamta K; Mehta, Aneesh K; Wolfe, Cameron R; Gomez, Carlos A; Beresnev, Tatiana; Mularski, Richard A; Paules, Catharine I; Kalil, Andre C; Branche, Angela R; Luetkemeyer, Annie; Zingman, Barry S; Voell, Jocelyn; Whitaker, Michael; Harkins, Michelle S; Davey, Richard T; Grossberg, Robert; George, Sarah L; Tapson, Victor; Short, William R; Ghazaryan, Varduhi; Benson, Constance A; Dodd, Lori E; Sweeney, Daniel A; Tomashek, Kay M
  3. Open Forum Infectious Diseases. 2023, Jun; 10(6): ofad290.
  1. 20.   Phase I/II study of PexaVec in combination with immune checkpoint inhibition in refractory metastatic colorectal cancer
  2. Monge, Cecilia; Xie, Changqing; Myojin, Yuta; Coffman, Kelley; Hrones, Donna Mabry; Wang, Sophie; Hernandez, Jonathan M; Wood, Bradford J; Levy, Elliot B; Juburi, Israa; Hewitt, Stephen M; Kleiner, David E; Steinberg, Seth M; Figg, William D; Redd, Bernadette; Homan,Philip; Cam, Maggie; Ruf, Benjamin; Duffy, Austin G; Greten, Tim F
  3. Journal for Immunotherapy of Cancer. 2023, Feb; 11(2):
  1. 21.   Imaging and biopsy of HIV-infected individuals undergoing analytic treatment interruption
  2. Lau, Chuen-Yen; Adan, Matthew A; Earhart, Jessica; Seamon, Cassie; Nguyen,Thuy; Savramis, Ariana; Adams, Lindsey; Zipparo, Mary-Elizabeth; Madeen,Erin; Huik, Kristi; Grossman, Zehava; Chimukangara, Benjamin; Wulan, Wahyu Nawang; Millo, Corina; Nath, Avindra; Smith, Bryan R; Ortega-Villa, Ana M; Proschan, Michael; Wood, Bradford J; Hammoud, Dima A; Maldarelli,Frank
  3. Frontiers in Medicine. 2022, Aug; 9: 979756.
  1. 22.   Clinical grade ACE2 as a universal agent to block SARS-CoV-2 variants
  2. Monteil, Vanessa; Eaton, Brett; Postnikova, Elena; Murphy, Michael; Braunsfeld, Benedict; Crozier,Ian; Kricek, Franz; Niederhöfer, Janine; Schwarzböck, Alice; Breid, Helene; Devignot, Stephanie; Klingström, Jonas; Thålin, Charlotte; Kellner, Max J; Christ, Wanda; Havervall, Sebastian; Mereiter, Stefan; Knapp, Sylvia; Sanchez Jimenez, Anna; Bugajska-Schretter, Agnes; Dohnal, Alexander; Ruf, Christine; Gugenberger, Romana; Hagelkruys, Astrid; Montserrat, Nuria; Kozieradzki, Ivona; Hasan Ali, Omar; Stadlmann, Johannes; Holbrook, Michael R; Schmaljohn, Connie; Oostenbrink, Chris; Shoemaker, Robert H; Mirazimi, Ali; Wirnsberger, Gerald; Penninger, Josef M
  3. EMBO Molecular Medicine. 2022, Jul 04; e15230.
  1. 23.   Efficacy of Cochleated Amphotericin B in Mouse and Human Mucocutaneous Candidiasis
  2. Desai, Jigar V; Urban,Amanda; Swaim,Doris; Colton, Benjamin; Kibathi, Lilian W; Ferrè, Elise M N; Stratton, Pamela; Merideth, Melissa A; Hunsberger, Sally; Matkovits, Theresa; Mannino, Raphael; Holland, Steven M; Tramont, Edmund; Lionakis, Michail S; Freeman, Alexandra F
  3. Antimicrobial Agents and Chemotherapy. 2022, Jun 14; e0030822.
  1. 24.   Safety and immunogenicity of an HIV-1 prefusion-stabilized envelope trimer (Trimer 4571) vaccine in healthy adults: A first-in-human open-label, randomized, dose-escalation, phase 1 clinical trial
  2. Houser, Katherine V; Gaudinski, Martin R; Happe, Myra; Narpala, Sandeep; Verardi, Raffaello; Sarfo, Edward K; Corrigan, Angela R; Wu, Richard; Rothwell, Ro Shauna; Novik, Laura; Hendel, Cynthia S; Gordon, Ingelise J; Berkowitz, Nina M; Cartagena, Cora Trelles; Widge, Alicia T; Coates, Emily E; Strom, Larisa; Hickman, Somia; Conan-Cibotti, Michelle; Vazquez, Sandra; Trofymenko, Olga; Plummer, Sarah; Stein, Judy; Case,Christopher; Nason, Martha; Biju, Andrea; Parchment, Danealle K; Changela, Anita; Cheng, Cheng; Duan, Hongying; Geng, Hui; Teng, I-Ting; Zhou, Tongqing; O'Connell, Sarah; Barry, Chris; Carlton, Kevin; Gall, Jason G; Flach, Britta; Doria-Rose, Nicole A; Graham, Barney S; Koup, Richard A; McDermott, Adrian B; Mascola, John R; Kwong, Peter D; Ledgerwood, Julie E
  3. EClinicalMedicine. 2022, Jun; 48: 101477.
  1. 25.   Improving Patient Advocacy in NCI Scientific Steering Committees and Task Forces
  2. Bangs, Rick; Lynn, Jean M; Obot,Evelyn; Osborne, Sherill; Norris, Kim
  3. Journal of the National Cancer Institute. 2022, May 12;
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel